aluates Reports

$ 0.0

Automative

Global Gynecology Drugs Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-26W1012

Global Gynecology Drugs Market Insights and Forecast to 2028

BUY CHAPTERS

Global Gynecology Drugs Market Research Report 2025

Code: QYRE-Auto-26W1012

Report

September 2025

Pages:83

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Pfizer Inc

Roche

AbbVie

Bayer

Merck

Abbott Laboratories

GlaxoSmithKline PLC

Johnson & Johnson

Sanofi

Novartis

Eli Lilly

Astrazeneca plc

Allergan plc

Amgen Inc

Chengdu Enwei Group

Johnson & Johnson

Gynecology Drugs Market Size

The global market for Gynecology Drugs was valued at US$ 53300 million in the year 2024 and is projected to reach a revised size of US$ 65800 million by 2031, growing at a CAGR of 3.1% during the forecast period.

Gynecology Drugs Market

Gynaecology is the field of medicine that focuses on women"s reproductive health issues, including the diagnosis and treatment of diseases of the female reproductive organs. It is usually combined with obstetrics (OB/GYN).

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Gynecology Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gynecology Drugs.

The Gynecology Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Gynecology Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Gynecology Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Gynecology Drugs Market Report

Report Metric	Details
Report Name	Gynecology Drugs Market
Accounted market size in year	US$ 53300 million
Forecasted market size in 2031	US$ 65800 million
CAGR	3.1%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Hormonal Therapy Non-hormonal Therapy
Segment by Application	Hospital Pharmacies Retail Pharmacies Online Pharmacies
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Pfizer, Roche, AbbVie, Bayer, Merck, Abbott Laboratories, GlaxoSmithKline, Johnson & Johnson, Sanofi, Novartis, Eli Lilly, AstraZeneca, Allergan, Amgen, Chengdu Enwei Group
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gynecology Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Gynecology Drugs Market growing?

Ans: The Gynecology Drugs Market witnessing a CAGR of 3.1% during the forecast period 2025-2031.

What is the Gynecology Drugs Market size in 2031?

Ans: The Gynecology Drugs Market size in 2031 will be US$ 65800 million.

Who are the main players in the Gynecology Drugs Market report?

Ans: The main players in the Gynecology Drugs Market are Pfizer, Roche, AbbVie, Bayer, Merck, Abbott Laboratories, GlaxoSmithKline, Johnson & Johnson, Sanofi, Novartis, Eli Lilly, AstraZeneca, Allergan, Amgen, Chengdu Enwei Group

What are the Application segmentation covered in the Gynecology Drugs Market report?

Ans: The Applications covered in the Gynecology Drugs Market report are Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

What are the Type segmentation covered in the Gynecology Drugs Market report?

Ans: The Types covered in the Gynecology Drugs Market report are Hormonal Therapy, Non-hormonal Therapy

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Gynecology Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Hormonal Therapy

1.2.3 Non-hormonal Therapy

1.3 Market by Application

1.3.1 Global Gynecology Drugs Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital Pharmacies

1.3.3 Retail Pharmacies

1.3.4 Online Pharmacies

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Gynecology Drugs Market Perspective (2020-2031)

2.2 Global Gynecology Drugs Growth Trends by Region

2.2.1 Global Gynecology Drugs Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Gynecology Drugs Historic Market Size by Region (2020-2025)

2.2.3 Gynecology Drugs Forecasted Market Size by Region (2026-2031)

2.3 Gynecology Drugs Market Dynamics

2.3.1 Gynecology Drugs Industry Trends

2.3.2 Gynecology Drugs Market Drivers

2.3.3 Gynecology Drugs Market Challenges

2.3.4 Gynecology Drugs Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Gynecology Drugs Players by Revenue

3.1.1 Global Top Gynecology Drugs Players by Revenue (2020-2025)

3.1.2 Global Gynecology Drugs Revenue Market Share by Players (2020-2025)

3.2 Global Gynecology Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Gynecology Drugs Revenue

3.4 Global Gynecology Drugs Market Concentration Ratio

3.4.1 Global Gynecology Drugs Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Gynecology Drugs Revenue in 2024

3.5 Global Key Players of Gynecology Drugs Head office and Area Served

3.6 Global Key Players of Gynecology Drugs, Product and Application

3.7 Global Key Players of Gynecology Drugs, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Gynecology Drugs Breakdown Data by Type

4.1 Global Gynecology Drugs Historic Market Size by Type (2020-2025)

4.2 Global Gynecology Drugs Forecasted Market Size by Type (2026-2031)

5 Gynecology Drugs Breakdown Data by Application

5.1 Global Gynecology Drugs Historic Market Size by Application (2020-2025)

5.2 Global Gynecology Drugs Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Gynecology Drugs Market Size (2020-2031)

6.2 North America Gynecology Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Gynecology Drugs Market Size by Country (2020-2025)

6.4 North America Gynecology Drugs Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Gynecology Drugs Market Size (2020-2031)

7.2 Europe Gynecology Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Gynecology Drugs Market Size by Country (2020-2025)

7.4 Europe Gynecology Drugs Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Gynecology Drugs Market Size (2020-2031)

8.2 Asia-Pacific Gynecology Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Gynecology Drugs Market Size by Region (2020-2025)

8.4 Asia-Pacific Gynecology Drugs Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Gynecology Drugs Market Size (2020-2031)

9.2 Latin America Gynecology Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Gynecology Drugs Market Size by Country (2020-2025)

9.4 Latin America Gynecology Drugs Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Gynecology Drugs Market Size (2020-2031)

10.2 Middle East & Africa Gynecology Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Gynecology Drugs Market Size by Country (2020-2025)

10.4 Middle East & Africa Gynecology Drugs Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Pfizer

11.1.1 Pfizer Company Details

11.1.2 Pfizer Business Overview

11.1.3 Pfizer Gynecology Drugs Introduction

11.1.4 Pfizer Revenue in Gynecology Drugs Business (2020-2025)

11.1.5 Pfizer Recent Development

11.2 Roche

11.2.1 Roche Company Details

11.2.2 Roche Business Overview

11.2.3 Roche Gynecology Drugs Introduction

11.2.4 Roche Revenue in Gynecology Drugs Business (2020-2025)

11.2.5 Roche Recent Development

11.3 AbbVie

11.3.1 AbbVie Company Details

11.3.2 AbbVie Business Overview

11.3.3 AbbVie Gynecology Drugs Introduction

11.3.4 AbbVie Revenue in Gynecology Drugs Business (2020-2025)

11.3.5 AbbVie Recent Development

11.4 Bayer

11.4.1 Bayer Company Details

11.4.2 Bayer Business Overview

11.4.3 Bayer Gynecology Drugs Introduction

11.4.4 Bayer Revenue in Gynecology Drugs Business (2020-2025)

11.4.5 Bayer Recent Development

11.5 Merck

11.5.1 Merck Company Details

11.5.2 Merck Business Overview

11.5.3 Merck Gynecology Drugs Introduction

11.5.4 Merck Revenue in Gynecology Drugs Business (2020-2025)

11.5.5 Merck Recent Development

11.6 Abbott Laboratories

11.6.1 Abbott Laboratories Company Details

11.6.2 Abbott Laboratories Business Overview

11.6.3 Abbott Laboratories Gynecology Drugs Introduction

11.6.4 Abbott Laboratories Revenue in Gynecology Drugs Business (2020-2025)

11.6.5 Abbott Laboratories Recent Development

11.7 GlaxoSmithKline

11.7.1 GlaxoSmithKline Company Details

11.7.2 GlaxoSmithKline Business Overview

11.7.3 GlaxoSmithKline Gynecology Drugs Introduction

11.7.4 GlaxoSmithKline Revenue in Gynecology Drugs Business (2020-2025)

11.7.5 GlaxoSmithKline Recent Development

11.8 Johnson & Johnson

11.8.1 Johnson & Johnson Company Details

11.8.2 Johnson & Johnson Business Overview

11.8.3 Johnson & Johnson Gynecology Drugs Introduction

11.8.4 Johnson & Johnson Revenue in Gynecology Drugs Business (2020-2025)

11.8.5 Johnson & Johnson Recent Development

11.9 Sanofi

11.9.1 Sanofi Company Details

11.9.2 Sanofi Business Overview

11.9.3 Sanofi Gynecology Drugs Introduction

11.9.4 Sanofi Revenue in Gynecology Drugs Business (2020-2025)

11.9.5 Sanofi Recent Development

11.10 Novartis

11.10.1 Novartis Company Details

11.10.2 Novartis Business Overview

11.10.3 Novartis Gynecology Drugs Introduction

11.10.4 Novartis Revenue in Gynecology Drugs Business (2020-2025)

11.10.5 Novartis Recent Development

11.11 Eli Lilly

11.11.1 Eli Lilly Company Details

11.11.2 Eli Lilly Business Overview

11.11.3 Eli Lilly Gynecology Drugs Introduction

11.11.4 Eli Lilly Revenue in Gynecology Drugs Business (2020-2025)

11.11.5 Eli Lilly Recent Development

11.12 AstraZeneca

11.12.1 AstraZeneca Company Details

11.12.2 AstraZeneca Business Overview

11.12.3 AstraZeneca Gynecology Drugs Introduction

11.12.4 AstraZeneca Revenue in Gynecology Drugs Business (2020-2025)

11.12.5 AstraZeneca Recent Development

11.13 Allergan

11.13.1 Allergan Company Details

11.13.2 Allergan Business Overview

11.13.3 Allergan Gynecology Drugs Introduction

11.13.4 Allergan Revenue in Gynecology Drugs Business (2020-2025)

11.13.5 Allergan Recent Development

11.14 Amgen

11.14.1 Amgen Company Details

11.14.2 Amgen Business Overview

11.14.3 Amgen Gynecology Drugs Introduction

11.14.4 Amgen Revenue in Gynecology Drugs Business (2020-2025)

11.14.5 Amgen Recent Development

11.15 Chengdu Enwei Group

11.15.1 Chengdu Enwei Group Company Details

11.15.2 Chengdu Enwei Group Business Overview

11.15.3 Chengdu Enwei Group Gynecology Drugs Introduction

11.15.4 Chengdu Enwei Group Revenue in Gynecology Drugs Business (2020-2025)

11.15.5 Chengdu Enwei Group Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Pfizer Inc

Roche

AbbVie

Bayer

Merck

Abbott Laboratories

GlaxoSmithKline PLC

Johnson & Johnson

Sanofi

Novartis

Eli Lilly

Astrazeneca plc

Allergan plc

Amgen Inc

Chengdu Enwei Group

Johnson & Johnson

List of Tables

Table 1. Global Gynecology Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Hormonal Therapy

Table 3. Key Players of Non-hormonal Therapy

Table 4. Global Gynecology Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Gynecology Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Gynecology Drugs Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Gynecology Drugs Market Share by Region (2020-2025)

Table 8. Global Gynecology Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Gynecology Drugs Market Share by Region (2026-2031)

Table 10. Gynecology Drugs Market Trends

Table 11. Gynecology Drugs Market Drivers

Table 12. Gynecology Drugs Market Challenges

Table 13. Gynecology Drugs Market Restraints

Table 14. Global Gynecology Drugs Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Gynecology Drugs Market Share by Players (2020-2025)

Table 16. Global Top Gynecology Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gynecology Drugs as of 2024)

Table 17. Ranking of Global Top Gynecology Drugs Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Gynecology Drugs Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Gynecology Drugs, Headquarters and Area Served

Table 20. Global Key Players of Gynecology Drugs, Product and Application

Table 21. Global Key Players of Gynecology Drugs, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Gynecology Drugs Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Gynecology Drugs Revenue Market Share by Type (2020-2025)

Table 25. Global Gynecology Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Gynecology Drugs Revenue Market Share by Type (2026-2031)

Table 27. Global Gynecology Drugs Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Gynecology Drugs Revenue Market Share by Application (2020-2025)

Table 29. Global Gynecology Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Gynecology Drugs Revenue Market Share by Application (2026-2031)

Table 31. North America Gynecology Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Gynecology Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Gynecology Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Gynecology Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Gynecology Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Gynecology Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Gynecology Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Gynecology Drugs Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Gynecology Drugs Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Gynecology Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Gynecology Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Gynecology Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Gynecology Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Gynecology Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Gynecology Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 46. Pfizer Company Details

Table 47. Pfizer Business Overview

Table 48. Pfizer Gynecology Drugs Product

Table 49. Pfizer Revenue in Gynecology Drugs Business (2020-2025) & (US$ Million)

Table 50. Pfizer Recent Development

Table 51. Roche Company Details

Table 52. Roche Business Overview

Table 53. Roche Gynecology Drugs Product

Table 54. Roche Revenue in Gynecology Drugs Business (2020-2025) & (US$ Million)

Table 55. Roche Recent Development

Table 56. AbbVie Company Details

Table 57. AbbVie Business Overview

Table 58. AbbVie Gynecology Drugs Product

Table 59. AbbVie Revenue in Gynecology Drugs Business (2020-2025) & (US$ Million)

Table 60. AbbVie Recent Development

Table 61. Bayer Company Details

Table 62. Bayer Business Overview

Table 63. Bayer Gynecology Drugs Product

Table 64. Bayer Revenue in Gynecology Drugs Business (2020-2025) & (US$ Million)

Table 65. Bayer Recent Development

Table 66. Merck Company Details

Table 67. Merck Business Overview

Table 68. Merck Gynecology Drugs Product

Table 69. Merck Revenue in Gynecology Drugs Business (2020-2025) & (US$ Million)

Table 70. Merck Recent Development

Table 71. Abbott Laboratories Company Details

Table 72. Abbott Laboratories Business Overview

Table 73. Abbott Laboratories Gynecology Drugs Product

Table 74. Abbott Laboratories Revenue in Gynecology Drugs Business (2020-2025) & (US$ Million)

Table 75. Abbott Laboratories Recent Development

Table 76. GlaxoSmithKline Company Details

Table 77. GlaxoSmithKline Business Overview

Table 78. GlaxoSmithKline Gynecology Drugs Product

Table 79. GlaxoSmithKline Revenue in Gynecology Drugs Business (2020-2025) & (US$ Million)

Table 80. GlaxoSmithKline Recent Development

Table 81. Johnson & Johnson Company Details

Table 82. Johnson & Johnson Business Overview

Table 83. Johnson & Johnson Gynecology Drugs Product

Table 84. Johnson & Johnson Revenue in Gynecology Drugs Business (2020-2025) & (US$ Million)

Table 85. Johnson & Johnson Recent Development

Table 86. Sanofi Company Details

Table 87. Sanofi Business Overview

Table 88. Sanofi Gynecology Drugs Product

Table 89. Sanofi Revenue in Gynecology Drugs Business (2020-2025) & (US$ Million)

Table 90. Sanofi Recent Development

Table 91. Novartis Company Details

Table 92. Novartis Business Overview

Table 93. Novartis Gynecology Drugs Product

Table 94. Novartis Revenue in Gynecology Drugs Business (2020-2025) & (US$ Million)

Table 95. Novartis Recent Development

Table 96. Eli Lilly Company Details

Table 97. Eli Lilly Business Overview

Table 98. Eli Lilly Gynecology Drugs Product

Table 99. Eli Lilly Revenue in Gynecology Drugs Business (2020-2025) & (US$ Million)

Table 100. Eli Lilly Recent Development

Table 101. AstraZeneca Company Details

Table 102. AstraZeneca Business Overview

Table 103. AstraZeneca Gynecology Drugs Product

Table 104. AstraZeneca Revenue in Gynecology Drugs Business (2020-2025) & (US$ Million)

Table 105. AstraZeneca Recent Development

Table 106. Allergan Company Details

Table 107. Allergan Business Overview

Table 108. Allergan Gynecology Drugs Product

Table 109. Allergan Revenue in Gynecology Drugs Business (2020-2025) & (US$ Million)

Table 110. Allergan Recent Development

Table 111. Amgen Company Details

Table 112. Amgen Business Overview

Table 113. Amgen Gynecology Drugs Product

Table 114. Amgen Revenue in Gynecology Drugs Business (2020-2025) & (US$ Million)

Table 115. Amgen Recent Development

Table 116. Chengdu Enwei Group Company Details

Table 117. Chengdu Enwei Group Business Overview

Table 118. Chengdu Enwei Group Gynecology Drugs Product

Table 119. Chengdu Enwei Group Revenue in Gynecology Drugs Business (2020-2025) & (US$ Million)

Table 120. Chengdu Enwei Group Recent Development

Table 121. Research Programs/Design for This Report

Table 122. Key Data Information from Secondary Sources

Table 123. Key Data Information from Primary Sources

Table 124. Authors List of This Report

List of Figures

Figure 1. Gynecology Drugs Picture

Figure 2. Global Gynecology Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Gynecology Drugs Market Share by Type: 2024 VS 2031

Figure 4. Hormonal Therapy Features

Figure 5. Non-hormonal Therapy Features

Figure 6. Global Gynecology Drugs Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Gynecology Drugs Market Share by Application: 2024 VS 2031

Figure 8. Hospital Pharmacies Case Studies

Figure 9. Retail Pharmacies Case Studies

Figure 10. Online Pharmacies Case Studies

Figure 11. Gynecology Drugs Report Years Considered

Figure 12. Global Gynecology Drugs Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Gynecology Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Gynecology Drugs Market Share by Region: 2024 VS 2031

Figure 15. Global Gynecology Drugs Market Share by Players in 2024

Figure 16. Global Top Gynecology Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gynecology Drugs as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Gynecology Drugs Revenue in 2024

Figure 18. North America Gynecology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Gynecology Drugs Market Share by Country (2020-2031)

Figure 20. United States Gynecology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Gynecology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Gynecology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Gynecology Drugs Market Share by Country (2020-2031)

Figure 24. Germany Gynecology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Gynecology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Gynecology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Gynecology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Gynecology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Gynecology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Gynecology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Gynecology Drugs Market Share by Region (2020-2031)

Figure 32. China Gynecology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Gynecology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Gynecology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Gynecology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Gynecology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Gynecology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Gynecology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Gynecology Drugs Market Share by Country (2020-2031)

Figure 40. Mexico Gynecology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Gynecology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Gynecology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Gynecology Drugs Market Share by Country (2020-2031)

Figure 44. Turkey Gynecology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Gynecology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Gynecology Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Pfizer Revenue Growth Rate in Gynecology Drugs Business (2020-2025)

Figure 48. Roche Revenue Growth Rate in Gynecology Drugs Business (2020-2025)

Figure 49. AbbVie Revenue Growth Rate in Gynecology Drugs Business (2020-2025)

Figure 50. Bayer Revenue Growth Rate in Gynecology Drugs Business (2020-2025)

Figure 51. Merck Revenue Growth Rate in Gynecology Drugs Business (2020-2025)

Figure 52. Abbott Laboratories Revenue Growth Rate in Gynecology Drugs Business (2020-2025)

Figure 53. GlaxoSmithKline Revenue Growth Rate in Gynecology Drugs Business (2020-2025)

Figure 54. Johnson & Johnson Revenue Growth Rate in Gynecology Drugs Business (2020-2025)

Figure 55. Sanofi Revenue Growth Rate in Gynecology Drugs Business (2020-2025)

Figure 56. Novartis Revenue Growth Rate in Gynecology Drugs Business (2020-2025)

Figure 57. Eli Lilly Revenue Growth Rate in Gynecology Drugs Business (2020-2025)

Figure 58. AstraZeneca Revenue Growth Rate in Gynecology Drugs Business (2020-2025)

Figure 59. Allergan Revenue Growth Rate in Gynecology Drugs Business (2020-2025)

Figure 60. Amgen Revenue Growth Rate in Gynecology Drugs Business (2020-2025)

Figure 61. Chengdu Enwei Group Revenue Growth Rate in Gynecology Drugs Business (2020-2025)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Gynecological Medical Devices Market Research Report 2025

Global Gynecological Surgical Instruments and Consumables Market Research Report 2025

Gynaecological Cancer Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Women Health Care Market Research Report 2024

Global Women s Health Market Research Report 2025

Global Gynecology Software Market Insights Forecast to 2030

Global Gynecological Conditions Medications Market Research Report 2024

Global Gynecological Endoscope Market Research Report 2025

Global Gynecology Devices Market Research Report 2024

Global Gynecological Instruments Market Research Report 2025

Global Gynaecological Examination Table Market Research Report 2025

Global Gynaecological Bed Market Insights Forecast to 2030

Global Women s Health Care Drugs Market Research Report 2024

Global Pharmaceuticals for Women s Health Market Research Report 2025

Global Reproductive Health Market Research Report 2024

Global Reproductive Health Testing Market Research Report 2024

Global Gynecology Hysteroscopes Market Research Report 2025

Gynecological Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Gynecological Supplements Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions